Travere Therapeutics
TVTX
TVTX
131 hedge funds and large institutions have $611M invested in Travere Therapeutics in 2019 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 47 increasing their positions, 43 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
3.46% less ownership
Funds ownership: 103.6% → 100.14% (-3.5%)
74% less call options, than puts
Call options by funds: $668K | Put options by funds: $2.56M
Holders
131
Holding in Top 10
–
Calls
$668K
Puts
$2.56M
Top Buyers
| 1 | +$17.2M | |
| 2 | +$5.74M | |
| 3 | +$5.52M | |
| 4 |
D.E. Shaw & Co
New York
|
+$4.24M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$3.76M |
Top Sellers
| 1 | -$20.2M | |
| 2 | -$17.2M | |
| 3 | -$7.08M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$5.89M |
| 5 |
PA
Perceptive Advisors
New York
|
-$5.4M |